The Human Hookworm Vaccine Initiative

 

HHVI Home

Progress & Achievements


HHVI Partners
 

About the Vaccine

About Hookworm:
   Hookworm Life Cycle
   Hookworm Prevention
   Travelers Information
   FAQ

Research Articles

How to Help

Contact Us

 

 

 

 

 

 

E-mail this page   Printable View

 The Human Hookworm Vaccine Initiative

 

Mission of the HHVI

Research & Development: To develop a safe, efficacious, and low-cost vaccine (the Human Hookworm Vaccine) in order to reduce the burden of disease caused by human hookworm infection.

Dissemination: To ensure that the Human Hookworm Vaccine is made available to impoverished people living in Africa, Asia, and the Americas.

Innovation: To conduct basic and applied research that will facilitate the development of new tools for hookworm control.

Advocacy: To make the scientific and lay communities aware of the importance of human hookworm infection and related neglected diseases as public health threats.

History of the HHVI 

    The HHVI is a product development partnership (PDP) founded in 2000 to develop a recombinant protein vaccine for human hookworm infection. Headquartered in Washington, D.C, the HHVI is a major program of the Sabin Vaccine Institute.